Center-Authored Papers

Filters: Author is Ferrara, James L M  [Clear All Filters]
Journal Article
Paczesny S, Krijanovski OI, Braun TM, Choi SW, Clouthier SG, Kuick R, Misek DE, Cooke KR, Kitko CL, Weyand A et al..  2009.  A biomarker panel for acute graft-versus-host disease.. Blood. 113(2):273-8. Abstract
Paczesny S, Braun TM, Levine JE, Hogan J, Crawford J, Coffing B, Olsen S, Choi SW, Wang H, Faca V et al..  2010.  Elafin is a biomarker of graft-versus-host disease of the skin.. Science translational medicine. 2(13):13ra2. Abstract
Holtan SG, Khera N, Levine JE, Chai X, Storer B, Liu HD, Inamoto Y, Chen GL, Mayer S, Arora M et al..  2016.  Late acute graft versus host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.. Blood. 128(19):2350-2358. Abstract
Kitko CL, Levine JE, Storer BE, Chai X, Fox DA, Braun TM, Couriel DR, Martin PJ, Flowers ME, Hansen JA et al..  2014.  Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.. Blood. 123(5):786-93. Abstract
Macmillan ML, Robin M, Harris AC, Defor TE, Martin PJ, Alousi A, Ho VT, Bolaños-Meade J, Ferrara JLM, Jones R et al..  2015.  A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(4):761-7. Abstract
Ferrara JLM, Harris AC, Greenson JK, Braun TM, Holler E, Teshima T, Levine JE, Choi SWJ, Huber E, Landfried K et al..  2011.  Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.. Blood. 118(25):6702-8. Abstract
Vander Lugt MT, Braun TM, Hanash S, Ritz J, Ho VT, Antin JH, Zhang Q, Wong C-H, Wang H, Chin A et al..  2013.  ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.. The New England journal of medicine. 369(6):529-39. Abstract